MRMarcelo Rudzinski

Marcelo Rudzinski

*This is an algorithmically generated author record based on publicly available information.

Marcelo Rudzinski has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Carina Argüelles

    Cátedra de Biología Molecular, Universidad Católica de las Misiones , Posadas , Argentina

    1 shared publication
  • Carina Francisca Argüelles

    Rare Diseases Community (RDCom), Cambridge, United Kingdom; Facultad de Ciencias de la Salud, Universidad Católica de las Misiones, Misiones, Argentina; Instituto de Biología Subtropical, Nodo Posadas, Universidad Nacional de Misiones (UNaM) - Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Misiones, Argentina

    1 shared publication
  • Cristóbal Couto

    Departamento de Oftalmología, Hospital de Clínicas José de San Martín , Buenos Aires , Argentina

    1 shared publication
  • Duarte

    Facultad de Ciencias de la Salud, Centro de Investigación, Universidad Católica de las Misiones (UCAMI), Posadas, Argentina

    1 shared publication
  • Gastón Moré

    Institute of Parasitology, University of Bern, Länggassstrasse 122, 3012, Bern, Switzerland

    1 shared publication
  • José R. Oubiña

    Instituto de Investigaciones en Microbiología y Parasitología Médica, Universidad de Buenos Aires - Consejo Nacional de Investigaciones Científicas y Técnicas (IMPaM, UBA-CONICET) , Ciudad Autónoma de Buenos Aires , Argentina

    1 shared publication

Latest Publications

  • Open Access

    Interferon-γ and IL-10 Release Assay for Patients with Ocular Toxoplasmosis

    by Marcelo Rudzinski, Lais Pardini, Mariana Bernstein, Gastón Moré, Marina Khoury, Silvana Carolina Duarte, Carina Argüelles, Silvia Reina, José Raúl Oubiña

    Peripheral blood mononuclear cells (PBMCs) from patients with ocular toxoplasmosis were challenged with Toxoplasma gondii lysate antigen (TLA) in a cytokine release assay (CRA), run during the inactive period of the disease. Increased interferon gamma (IFN-γ) levels were detected after PBMC stimulation with either ME49 reference strain (P = 0.0015) or local TgCkAr-11-9 isolate (P = 0.0012), as compared with those recorded under basal conditions. TLA from TgCkAr11-9 isolate induced a higher release of IFN-γ than ME49 strain CRA from all tested patients (P = 0.02). The median value of IFN-γ release on TgCkAr-11-9 stimulation (26.03 pg/mL) allowed the classification of patients into high– or low–/non–IFN-γ releasers. Clinical correlations were established with both groups. The results obtained in this study suggest the need to include local strains when performing CRA with T. gondii TLA.


  • Immune Mediators against Toxoplasma Gondii during Reactivation of Toxoplasmic Retinochoroiditis

    by Marcelo Rudzinski, Carina Argüelles, Cristóbal Couto, José R. Oubiña, Silvia Reina

    Purpose: The purpose of this article is to analyze possible associations between systemic and ocular cytokine levels and specific clinical ophthalmologic signs from patients with a reactivation of toxoplasmic retinochoroiditis (RTR). Methods: A total of 18 patients with an active RTR episode, 8 patients with inactive scars, and 14 control patients were included in the study. Serum samples and aqueous humor (AH) samples were analyzed for IFN (interferon)-γ, interleukin (IL)-10, and IL-6 levels by ELISA. Inflammation grade, location, and size of the retinochoroidal active lesion, sampling time, and time to resolution were recorded. Results: A significantly negative correlation between AH and serum levels of IFN-γ was detected (p < 0.05). Patients with an AH IFN-γ/IL-10 ratio lower than 1 were associated with the longest time to resolution and/or severe complications. Conclusion: Serum IFN-γ levels may be used as a prognostic marker for both time to resolution and the development of possible severe complications during a given RTR episode.